Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
133%(4 trials)
Terminated
2(29%)

Phase Distribution

Ph early_phase_1
1
14%
Ph phase_3
1
14%
Ph phase_1
1
14%
Ph phase_2
4
57%

Phase Distribution

2

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Terminated(3)

Detailed Status

Completed3
Terminated2
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 24 (57.1%)
Phase 31 (14.3%)

Trials by Status

completed343%
terminated229%
not_yet_recruiting114%
withdrawn114%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruitingphase_2

Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy

NCT07145268
withdrawnearly_phase_1

A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment

NCT05550519
completedphase_2

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection

NCT04585789
terminatedphase_1

A Single and Multiple Ascending Dose Study of JNJ-64457744

NCT05423106
terminatedphase_2

A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection

NCT04398134
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07145268Phase 2

Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy

Not Yet Recruiting
NCT05550519Early Phase 1

A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment

Withdrawn
NCT04585789Phase 2

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection

Completed
NCT05423106Phase 1

A Single and Multiple Ascending Dose Study of JNJ-64457744

Terminated
NCT04398134Phase 2

A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection

Terminated
NCT00065507Phase 3

Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation

Completed
NCT00298363Phase 2

Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7